Korean Cannabinoid Association Wants to Leverage Blockchain for Cannabidiol Clinical Trials

The Korean Cannabinoid Association (KCA) said at a conference in Seoul on Monday that it intended to initiate a project to carry out clinical pilots related to cannabidiol (CBD), a constituent of cannabis that is used in multiple sclerosis and epilepsy therapies among others. The KCA will launch the project via Prasm, a decentralized bioinformatic network that leverages artificial intelligence (AI) and blockchain technologies.

Kwon Yong-hyun, director of Prasm and president of the KCA, commented on the project:

“Due to the prejudice that hemp is a drug, Korean medical society has been reluctant to conduct any clinical studies that

...read more at https://cryptovest.com/news/korean-cannabinoid-association-wants-to-leverage-blockchain-for-cannabidiol-clinical-trials/